QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
BRCA Gene Mutations in Women According to the US National Cancer Institute, women with a faulty BRCA mutation are about 5 times more likely to develop breast cancer and 15-40% will develop ovarian cancer, compared to 1.4% of the general…
QUEST has reported often about the need to find a way to distinguish aggressive from non-aggressive prostate cancer in the diagnostic stage. So far, the search is on but the answers are elusive. Now, researchers at Northwestern, using samples from…
A Young Man of Action Looking back, it’s easy to see that Purdy is a man with a history of taking action. He was always a St. Louis Browns fan, even when the Cardinals were the big name in St….
The more we know about PSA testing, the more useful the information is, but there is still room for improvement. We now know that some men are high PSA producers and some are low PSA producers. The estimate is that…
Dr. Kevin T. McVary is Professor and Chairman of Urology at Southern Illinois University School of Medicine in Springfield, IL and a specialist in prostate diseases and erectile dysfunction Although BPH is a common condition, it doesn’t always result in…
The FDA approved the production and use of Choline C 11 injections to help detect recurrent prostate cancer. This PET imaging agent is especially useful when PSA levels are increasing after earlier treatment for prostate cancer but conventional imaging tests…
A large body of evidence suggests a genetic cause for prostate cancer, a connection stronger than for any other common type of cancer. Some of these genetic factors may be inherited and others may be acquired during life. It is…
In my practice, I recommend an erectile function rehabilitation program that has two phases. The first phase is designed to minimize the damage to the erectile nerves (sometimes called the “cavernosal” nerves) that occurs from the radical prostatectomy procedure. I…
In the process, they also plan to learn more about who would benefit from active surveillance after diagnosis and who would not. Because a large group of men across the United States have participated in active surveillance programs, detailed clinical…
Edward M. Messing, MD, FACS; Winfield W. Scott Professor, Chairman, Department of Urology, Professor of Oncology and Pathology, University of Rochester Prostate cancer detected and treated early can result in a possible cure. Metastatic prostate cancer (cancer spread from the…
"*" indicates required fields
